FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1918751531> ?p ?o ?g. }

• W1918751531 endingPage "3287" @default.
• W1918751531 startingPage "3278" @default.
• W1918751531 abstract "Psoriasis is a chronic autoimmune disease affecting the skin and characterized by aberrant keratinocyte proliferation and function. Immune cells infiltrate the skin and release proinflammatory cytokines that play important roles in psoriasis. The Th17 network, including IL-23 and IL-22, has recently emerged as a critical component in the pathogenesis of psoriasis. IL-22 and IL-23 signaling is dependent on the JAK family of protein tyrosine kinases, making JAK inhibition an appealing strategy for the treatment of psoriasis. In this study, we report the activity of SAR-20347, a small molecule inhibitor with specificity for JAK1 and tyrosine kinase 2 (TYK2) over other JAK family members. In cellular assays, SAR-20347 dose dependently (1 nM-10 μM) inhibited JAK1- and/or TYK2-dependent signaling from the IL-12/IL-23, IL-22, and IFN-α receptors. In vivo, TYK2 mutant mice or treatment of wild-type mice with SAR-20347 significantly reduced IL-12-induced IFN-γ production and IL-22-dependent serum amyloid A to similar extents, indicating that, in these models, SAR-20347 is probably acting through inhibition of TYK2. In an imiquimod-induced psoriasis model, the administration of SAR-20347 led to a striking decrease in disease pathology, including reduced activation of keratinocytes and proinflammatory cytokine levels compared with both TYK2 mutant mice and wild-type controls. Taken together, these data indicate that targeting both JAK1- and TYK2-mediated cytokine signaling is more effective than TYK2 inhibition alone in reducing psoriasis pathogenesis." @default.
• W1918751531 created "2016-06-24" @default.
• W1918751531 creator A5001389322 @default.
• W1918751531 creator A5002180143 @default.
• W1918751531 creator A5016737497 @default.
• W1918751531 creator A5021415221 @default.
• W1918751531 creator A5040073201 @default.
• W1918751531 creator A5044483629 @default.
• W1918751531 creator A5074865959 @default.
• W1918751531 creator A5076921042 @default.
• W1918751531 creator A5079609036 @default.
• W1918751531 creator A5087619761 @default.
• W1918751531 creator A5088256643 @default.
• W1918751531 creator A5089920396 @default.
• W1918751531 date "2014-08-25" @default.
• W1918751531 modified "2023-10-10" @default.
• W1918751531 title "Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis" @default.
• W1918751531 cites W1500535698 @default.
• W1918751531 cites W1507781793 @default.
• W1918751531 cites W1939997832 @default.
• W1918751531 cites W1967350651 @default.
• W1918751531 cites W1971708477 @default.
• W1918751531 cites W1973209866 @default.
• W1918751531 cites W1976291381 @default.
• W1918751531 cites W1979408807 @default.
• W1918751531 cites W1982657393 @default.
• W1918751531 cites W1989001888 @default.
• W1918751531 cites W2001981959 @default.
• W1918751531 cites W2004650652 @default.
• W1918751531 cites W2012097026 @default.
• W1918751531 cites W2013143792 @default.
• W1918751531 cites W2019447833 @default.
• W1918751531 cites W2026906356 @default.
• W1918751531 cites W2047386018 @default.
• W1918751531 cites W2060523664 @default.
• W1918751531 cites W2095128503 @default.
• W1918751531 cites W2096890891 @default.
• W1918751531 cites W2102889851 @default.
• W1918751531 cites W2105842551 @default.
• W1918751531 cites W2106464597 @default.
• W1918751531 cites W2108270917 @default.
• W1918751531 cites W2110427394 @default.
• W1918751531 cites W2113628816 @default.
• W1918751531 cites W2121008892 @default.
• W1918751531 cites W2125810931 @default.
• W1918751531 cites W2126087693 @default.
• W1918751531 cites W2132776121 @default.
• W1918751531 cites W2151734278 @default.
• W1918751531 cites W2155582127 @default.
• W1918751531 cites W2159513688 @default.
• W1918751531 cites W4255303081 @default.
• W1918751531 doi "https://doi.org/10.4049/jimmunol.1400205" @default.
• W1918751531 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4170002" @default.
• W1918751531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25156366" @default.
• W1918751531 hasPublicationYear "2014" @default.
• W1918751531 type Work @default.
• W1918751531 sameAs 1918751531 @default.
• W1918751531 citedByCount "73" @default.
• W1918751531 countsByYear W19187515312014 @default.
• W1918751531 countsByYear W19187515312015 @default.
• W1918751531 countsByYear W19187515312016 @default.
• W1918751531 countsByYear W19187515312017 @default.
• W1918751531 countsByYear W19187515312018 @default.
• W1918751531 countsByYear W19187515312019 @default.
• W1918751531 countsByYear W19187515312020 @default.
• W1918751531 countsByYear W19187515312021 @default.
• W1918751531 countsByYear W19187515312022 @default.
• W1918751531 countsByYear W19187515312023 @default.
• W1918751531 crossrefType "journal-article" @default.
• W1918751531 hasAuthorship W1918751531A5001389322 @default.
• W1918751531 hasAuthorship W1918751531A5002180143 @default.
• W1918751531 hasAuthorship W1918751531A5016737497 @default.
• W1918751531 hasAuthorship W1918751531A5021415221 @default.
• W1918751531 hasAuthorship W1918751531A5040073201 @default.
• W1918751531 hasAuthorship W1918751531A5044483629 @default.
• W1918751531 hasAuthorship W1918751531A5074865959 @default.
• W1918751531 hasAuthorship W1918751531A5076921042 @default.
• W1918751531 hasAuthorship W1918751531A5079609036 @default.
• W1918751531 hasAuthorship W1918751531A5087619761 @default.
• W1918751531 hasAuthorship W1918751531A5088256643 @default.
• W1918751531 hasAuthorship W1918751531A5089920396 @default.
• W1918751531 hasBestOaLocation W19187515311 @default.
• W1918751531 hasConcept C112392421 @default.
• W1918751531 hasConcept C126322002 @default.
• W1918751531 hasConcept C130523297 @default.
• W1918751531 hasConcept C154390347 @default.
• W1918751531 hasConcept C164027704 @default.
• W1918751531 hasConcept C170493617 @default.
• W1918751531 hasConcept C180361614 @default.
• W1918751531 hasConcept C203014093 @default.
• W1918751531 hasConcept C2775960820 @default.
• W1918751531 hasConcept C2776914184 @default.
• W1918751531 hasConcept C2778690821 @default.
• W1918751531 hasConcept C2779112978 @default.
• W1918751531 hasConcept C2780564577 @default.
• W1918751531 hasConcept C502942594 @default.
• W1918751531 hasConcept C71924100 @default.
• W1918751531 hasConcept C86803240 @default.

• next